A research report on the global stem cells market, published by Transparency Market Research (TMR), estimates the market to record a healthy CAGR of 24.20% during the period from 2012 and 2018. In 2013, the market reached US$26.2 bn and it is likely to attain a value of US$119.5 bn by the end of the forecast period.The research report is titled “Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018.”
Browse the full Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/stem-cells-market.html
A stem cell is an undifferentiated biological cell, which is capable of breaking into an indefinite number of cells of the same type through mitosis. Multicellular organisms, such as humans and animals, are made up of these cells. The rising awareness about the therapeutic benefits of stem cells in the treatment of various diseases is boosting their popularity across the world. The technical advancement in stem cell therapies is expected to propel this market during the forecast period.
On the other hand, strict government regulations regarding the harvesting of stem cells and the high cost associated with the treatment are expected to hamper the growth of this market in the coming years.
While preparing this report, analysts have performed a comprehensive analysis of the global stem cells market on the basis of product, technology, application, and region. On the regional basis, the worldwide market for stem cells has been categorized into Asia, Europe, North America, and the Rest of the World.
North America led the overall market in 2011 with a majority share and was followed by Europe, which held a share of 25% in the global market. The high prevalence of neurological and cardiovascular disorders in North America has boosted the stem cells market in this region over the past few years, states the report.
The study further notes that analysts expect Asia to report a double-digit rise in the global market for stem cells during the forecast period. The rapid growth in medical tourism and the significant increase in the market for contract research outsourcing in this region are likely to propel the stem cells market in Asia.
Product-wise, the market has been grouped into human embryonic stem cells, adult stem cells, rat neural stem cells, induced pluripotent stem cells, and very small embryonic-like stem cells. The adult stem cells segment leads the global market. The easy procedure of harvesting adult stem cell and the high rate of acceptance of these cells by the human body are the key factors driving this market segment.
Based on application, the report has classified the market into regenerative medicine and drug discovery and development. The demand for stem cells is higher in the regenerative medicine segment than the drug discovery and development segment. Hematology, cardiovascular and myocardial infarction, orthopedics, neurology, liver disorders, oncology, diabetes, and incontinence, and various types of injuries are the major sub-segments of the regenerative medicine segment.
By technology, the market has been segmented into stem cell acquisition, stem cell production, stem cell cryopreservation, and stem cell expansion and sub-culture. The stem cell acquisition segment is recording the fastest growth among all the technology segments, states the report.
Some of the key enterprises operating in the global stem cells market, namely, Stemcell Technologies Inc., Biotime Inc., Osiris Therapeutics, Cytori Therapeutics Inc., Cellular Engineering Technologies, Cellartis AB, Celgene Corp. Inc., California Stem Cell Inc., Brainstorm Cell Therapeutics, Bioheart, Angel Biotechnology, and Advanced Cell Technology have been profiled in this study.
The global stem cells market is segmented into:
- Adult Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neuronal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Rat Neural Stem Cells
- Very Small Embryonic-Like Stem Cells
- Stem Cell Acquisition
- Bone Marrow Harvest for Stem Cells
- Apheresis for Stem Cells
- Umbilical Cord Blood
- Stem Cell Production
- Therapeutic Cloning for Stem Cells
- Stem Cells Production By In Vitro Fertilization
- Stem Cell Isolation
- Stem Cell Culture
- Stem Cell Cryopreservation
- Stem Cells Expansion and Sub-Culture
- Drug Discovery and Development
- Regenerative Medicine
- Cardiovascular and Myocardial Infarction
- Wound Care
- Spinal Cord Injuries
- Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)
- Liver Disorders
- Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453